Stockreport

Immunocore Reports Second Quarter 2022 Financial Results and Provides Business Update

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF Immunocore Reports Second Quarter 2022 Financial Results and Provides Business Update KIMMTRAK® (tebentafusp) now approved in over 30 countries with commercial launches [Read more]